신희철 교수
Hee Chul Shin
서울대학교 · 생화학·유전·분자생물학
연구실 소개
신희철 교수의 연구실은 암의 분자적 기전과 생물학적 마커를 중심으로, 특히 유전적 변형과 생체 정보를 기반으로 한 암 조기 진단 및 개인 맞춤 치료 전략을 개발하고 있습니다. 주로 암의 유전적 특성과 전이성 병소 간의 수용체 상태 변화를 분석하여 치료 반응 예측 및 환자 관리 개선에 기여하고 있으며, 신규 바이오마커 및 NGS 기반 다유전자 패널 검사의 임상적 활용 가능성을 탐색하고 있습니다. 특히 유방암의 전이성 병소에서의 수용체 상태 이질성과 관련된 임상적 영향을 규명하는 데 초점을 맞추고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15Our data suggest that clinical and histologic assessments of the response to chemopreventive agents may be insufficient to determine their efficacy and that critical genetic alterations could be used as independent biomarkers to augment the ability to evaluate the efficacy of such agents.
Plasma processes cause current to flow through the thin oxide and the resultant plasma-induced damage can be simulated and modelled as damage produced by constant-current (or voltage) electrical stress. Plasma processing causes MOSFET parameter degradation, from which one can deduce the plasma charging current. Since the scattering of post-damage device parameters is due to a reproducible variation of stress current across the wafer, one can easily analyse the effect of device geometry on damage
NGS-based multiple-gene panel testing improved the detection rates of deleterious mutations and provided a cost-effective cancer risk assessment.
In acute leukemia, leukemic infiltration of the breast is extremely rare. We report a case of biphenotypic acute leukemia (BAL) that presented as a breast mass. A 30-year-old woman presented with a 4-month history of a right breast mass with nipple discharge and easy fatigue. She had received chemotherapy and peripheral blood stem cell transplantation for BAL and had been in complete remission for the last 2 years. Core needle biopsy of the breast mass revealed monomorphous infiltrates of blast
Discordance in receptor status and tumor phenotype between primary breast cancer and corresponding metastatic lesions was observed. Patients with concordant TNP had worse long-term outcomes than patients with concordant non-TNP and discordant TNP between primary and metastatic breast cancer. Identifying the receptor status of metastatic lesions may lead to improvements in patient management and survival.
1039 Background: The receptor status including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) of metastases may be different from that of the primary breast cancer. This discordance of receptor status may influence patient prognosis. We investigated discordance of receptor status between primary breast cancer and distant metastases in the same patients and its effect on prognosis. Methods: ER, PR, and HER2 status in metastases were availab
e13110 Background: Next-generation sequencing technology allows the simultaneous sequencing of multiple target genes. We developed a gene panel containing 64 genes which were associated with various hereditary cancers. This study was performed to evaluate the frequency of pathogenic mutations associated with hereditary cancer among Korean patients at high risk hereditary breast cancer using multi-gene sequencing panel. Methods: A total of 252 breast cancer patients with high-risk hereditary canc
e11503 Background: It has become important in the preoperative work up of breast cancer patients to analyze estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 in core needle biopsy (CNB). These factors reflect response or resistance to endocrine therapy, chemotherapy and target therapy. Furthermore, factors help to select adjuvant or neoadjuvant treatment. For accuracy of ER, PR, HER2, and Ki67 in CNB, we compared the results of CNB and
대표 연구 분야
신희철 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.